April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Spectral Domain-optical Coherence Tomography In Irvine-gass Syndrome
Author Affiliations & Notes
  • Gaetano Zinzanella
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Angelo M. Minnella
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Maria Cristina Savastano
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Giacomilde Mazzone
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Matteo Federici
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Mariangela Gari
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Lucilla Barbano
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Benedetto Falsini
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Emilio Balestrazzi
    Inst Ophthalmology, Catholic University, Rome, Italy
  • Footnotes
    Commercial Relationships  Gaetano Zinzanella, None; Angelo M. Minnella, None; Maria Cristina Savastano, None; Giacomilde Mazzone, None; Matteo Federici, None; Mariangela Gari, None; Lucilla Barbano, None; Benedetto Falsini, None; Emilio Balestrazzi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3696. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gaetano Zinzanella, Angelo M. Minnella, Maria Cristina Savastano, Giacomilde Mazzone, Matteo Federici, Mariangela Gari, Lucilla Barbano, Benedetto Falsini, Emilio Balestrazzi; Spectral Domain-optical Coherence Tomography In Irvine-gass Syndrome. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3696.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report morphological evaluation up to 12-months by spectral domain-optical coherence tomography (SD-OCT) in patients with cystic macular edema (CME) after cataract surgery (Irvine-Gass syndrome) receiving systemic therapy with oral acetazolamide and topical indomethacin.

Methods: : Fifteen eyes with Irvine-Gass syndrome were evaluated. An observational period of 3 months after surgery was considered before starting therapy. In this interventional case series study patients underwent ocular ophthalmological examinations. Repeated measures analysis of variance (ANOVA) was used to compare mean values

Results: : Mean (±SD) central macular thickness by SD-OCT was 530 (±98.1), 385.6 (±55.1), 339 (±32.3) and 316.2 (±27.0) µm at baseline, 3, 6, and 12 months of follow-up respectively (P<0.001). Eyes with interruption of inner segment/outer segment (IS/OS) junction at baseline (20%) showed a persistent damage of the photoreceptor junction and not complete visual acuity restoration or patient complains at the end of follow-up. Mean (±SD) BSCVA was 0.6 (±0.2), 0.2 (±0.1), 0.16 (±0.1) and 0.09 (±0.07) logMAR at baseline, 3, 6, and 12-month follow-up respectively (P< 0.001)

Conclusions: : SD-OCT detects retinal findings including photoreceptor IS/OS junction changes in patients with Irvine-Gass syndrome. Oral acetazolamide and topical indomethacin could be recommended as an efficacious therapy of this disease

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • carbonic anhydrase 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×